<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="t0005">
 <label>Table 1</label>
 <caption>
  <p>Summary of 54 FDA approved antiviral drugs selected for molecular docking studies.</p>
 </caption>
 <alt-text id="al0025">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Drugs</th>
    <th>Abbreviation</th>
    <th>PubChem ID</th>
    <th>Inhibitors class</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Idoxuridine</td>
    <td>IDU</td>
    <td>5905</td>
    <td rowspan="3">5-Substituted 2′-deoxyuridine analogues</td>
   </tr>
   <tr>
    <td>Trifluridine</td>
    <td>TFT</td>
    <td>6256</td>
   </tr>
   <tr>
    <td>Brivudine</td>
    <td>BVDU</td>
    <td>446727</td>
   </tr>
   <tr>
    <td>Vidarabine</td>
    <td>VDR</td>
    <td>21704</td>
    <td rowspan="3">Nucleoside analogues</td>
   </tr>
   <tr>
    <td>Entecavir</td>
    <td>ETV</td>
    <td>135398508</td>
   </tr>
   <tr>
    <td>Telbivudine</td>
    <td>LdT</td>
    <td>159269</td>
   </tr>
   <tr>
    <td>Foscarnet</td>
    <td>PFA</td>
    <td>3415</td>
    <td>Pyrophosphate analogues</td>
   </tr>
   <tr>
    <td>Zidovudine</td>
    <td>AZT</td>
    <td>35370</td>
    <td rowspan="7">Nucleoside reverse transcriptase (RT) inhibitors (NRTIs)</td>
   </tr>
   <tr>
    <td>Didanosine</td>
    <td>ddI</td>
    <td>135398739</td>
   </tr>
   <tr>
    <td>Zalcitabine</td>
    <td>ddC</td>
    <td>24066</td>
   </tr>
   <tr>
    <td>Stavudine</td>
    <td>d4T</td>
    <td>18283</td>
   </tr>
   <tr>
    <td>Lamivudine</td>
    <td>3TC</td>
    <td>60825</td>
   </tr>
   <tr>
    <td>Abacavir</td>
    <td>ABC</td>
    <td>441300</td>
   </tr>
   <tr>
    <td>Emtricitabine</td>
    <td>(−)FTC</td>
    <td>60877</td>
   </tr>
   <tr>
    <td>Nevirapine</td>
    <td>NVP</td>
    <td>4463</td>
    <td rowspan="5">Nonnucleoside reverse transcriptase inhibitors (NNRTIs)</td>
   </tr>
   <tr>
    <td>Delavirdine</td>
    <td>DLV</td>
    <td>5625</td>
   </tr>
   <tr>
    <td>Efavirenz</td>
    <td>EFV</td>
    <td>64139</td>
   </tr>
   <tr>
    <td>Etravirine</td>
    <td>ETR</td>
    <td>193962</td>
   </tr>
   <tr>
    <td>Rilpivirine</td>
    <td>RPV</td>
    <td>6451164</td>
   </tr>
   <tr>
    <td>Saquinavir</td>
    <td>SQV</td>
    <td>441243</td>
    <td rowspan="15">Protease inhibitors</td>
   </tr>
   <tr>
    <td>Ritonavir</td>
    <td>RTV</td>
    <td>392622</td>
   </tr>
   <tr>
    <td>Indinavir</td>
    <td>IDV</td>
    <td>5362440</td>
   </tr>
   <tr>
    <td>Nelfinavir</td>
    <td>NFV</td>
    <td>64143</td>
   </tr>
   <tr>
    <td>Amprenavir</td>
    <td>APV</td>
    <td>65016</td>
   </tr>
   <tr>
    <td>Atazanavir</td>
    <td>ATV</td>
    <td>148192</td>
   </tr>
   <tr>
    <td>Fosamprenavir</td>
    <td>FPV</td>
    <td>131536</td>
   </tr>
   <tr>
    <td>Tipranavir</td>
    <td>TPV</td>
    <td>54682461</td>
   </tr>
   <tr>
    <td>Darunavir</td>
    <td>DRV</td>
    <td>213039</td>
   </tr>
   <tr>
    <td>Telaprevir</td>
    <td>TVR</td>
    <td>3010818</td>
   </tr>
   <tr>
    <td>Boceprevir</td>
    <td>BOC</td>
    <td>10324367</td>
   </tr>
   <tr>
    <td>Simeprevir</td>
    <td>SMV</td>
    <td>24873435</td>
   </tr>
   <tr>
    <td>Asunaprevir</td>
    <td>ASV</td>
    <td>16076883</td>
   </tr>
   <tr>
    <td>Paritaprevir</td>
    <td>PTV</td>
    <td>45110509</td>
   </tr>
   <tr>
    <td>Grazoprevir</td>
    <td>GZR</td>
    <td>44603531</td>
   </tr>
   <tr>
    <td>Raltegravir</td>
    <td>RAL</td>
    <td>54671008</td>
    <td rowspan="3">Integrase inhibitors</td>
   </tr>
   <tr>
    <td>Elvitegravir</td>
    <td>EVG</td>
    <td>5277135</td>
   </tr>
   <tr>
    <td>Dolutegravir</td>
    <td>DTG</td>
    <td>54726191</td>
   </tr>
   <tr>
    <td>Docosanol</td>
    <td>C22</td>
    <td>12620</td>
    <td rowspan="2">Entry inhibitors</td>
   </tr>
   <tr>
    <td>Maraviroc</td>
    <td>MVC</td>
    <td>3002977</td>
   </tr>
   <tr>
    <td>Acyclovir</td>
    <td>ACV</td>
    <td>135398513</td>
    <td rowspan="6">Acyclic guanosine analogues</td>
   </tr>
   <tr>
    <td>Ganciclovir</td>
    <td>GCV</td>
    <td>135398740</td>
   </tr>
   <tr>
    <td>Famciclovir</td>
    <td>FCV</td>
    <td>3324</td>
   </tr>
   <tr>
    <td>Valacyclovir</td>
    <td>VACV</td>
    <td>135398742</td>
   </tr>
   <tr>
    <td>Penciclovir</td>
    <td>PCV</td>
    <td>135398748</td>
   </tr>
   <tr>
    <td>Valganciclovir</td>
    <td>VGCV</td>
    <td>135413535</td>
   </tr>
   <tr>
    <td>Cidofovir</td>
    <td>CDV</td>
    <td>60613</td>
    <td>Acyclic nucleoside phosphonate analogues</td>
   </tr>
   <tr>
    <td>Amantadine</td>
    <td>AMT</td>
    <td>2130</td>
    <td rowspan="8">Influenza virus inhibitors</td>
   </tr>
   <tr>
    <td>Ribavirin</td>
    <td>RBV</td>
    <td>37542</td>
   </tr>
   <tr>
    <td>Rimantadine</td>
    <td>RIM</td>
    <td>5071</td>
   </tr>
   <tr>
    <td>Zanamivir</td>
    <td>ZAN</td>
    <td>60855</td>
   </tr>
   <tr>
    <td>Oseltamivir</td>
    <td>OTV</td>
    <td>65028</td>
   </tr>
   <tr>
    <td>Laninamivir octanoate</td>
    <td>LO</td>
    <td>9847629</td>
   </tr>
   <tr>
    <td>Peramivir</td>
    <td>PRV</td>
    <td>154234</td>
   </tr>
   <tr>
    <td>Favipiravir</td>
    <td>FPV</td>
    <td>492405</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
